I have been asked to recommend what guidance the FDA should provide to pharma companies for social media. Here are my recommendations.. Continue reading
- The IMS Institute for Healthcare Informatics states that “the strategies that pharmaceutical companies use to engage with social media could be categorized as low-risk and less innovative than those employed in other industries.”
- The pharmaceutical industry has been slow to embrace social media.
- One reason is the lack of guidance from health regulators about using social media. In the US, for example.
- Users of social media now expect to be able to have a conversation with pharmaceutical companies when they face uncertainties.
KEY TAKEAWAY: It was going to change business forever. It was going to make traditional advertising irrelevant. It was going to revolutionize marketing. It was social media marketing and it’s been the biggest bullshit ever shoveled on marketers. Continue reading
KEY TAKEAWAY: Facebook’s objective was to keep users addicted to social media as much as possible, but now that Facebook has become nothing but a media company they don’t want to play by the same rules as other media companies. The risks of advertising on Facebook are too great while the rewards are too few. Continue reading
KEY TAKEAWAY: Social media is being used by online health seekers, but the latest reports, of fake news and bogus ads, should be a concern to all pharma marketers who seem to have lost control of the message. Continue reading
KEY TAKEAWAY: According to the Times “If I were a Facebook executive, I might feel a Frankensteinian sense of unease these days. The company has been hit with a series of scandals that have bruised its image, enraged its critics and opened up the possibility that in its quest for global dominance, Facebook may have created something it can’t fully control.” And they want pharma to advertise more? Continue reading
KEY TAKEAWAY: Facebook wants pharma money and they want it for everything from advertising new drugs to clinical trials but obstacles still remain. Continue reading